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Introduction
Elevated myocardial triglyceride levels have been
observed within the myocardium of diabetic and obese
individuals. Use of cocaine leads to cardiomyopathy and
precipitation of cardiovascular disease such as myocardial
infarction, ventricular arrhythmias, and left ventricular
dysfunction. Proton magnetic resonance spectroscopy
(1H-MRS) has been applied to measure lipid overload in
the human heart [1].
Purpose
The primary goal of the present study was to evaluate the
myocardial fat in cocaine abusers. We applied 1H-MRS to
quantify myocardial septal triglyceride content compared
to the non-cocaine users to ascertain the prevalence and
severity of cardiac steatosis among cocaine-use patients.
Methods
MRI/MRS studies were performed using a 3.0 T scanner
(Tim Trio, Siemens) on 44 participants (32 cocaine users,
and 12 non-users) with informed content. To measure left
ventricular function, the entire heart was imaged in short-
axis orientation using a retrospectively gated TrueFisp
sequence. The short-axis along with the two and four
chamber views were used to position the spectroscopic
volume (6-8 ml voxel) within the interventricular septum.
Myocardial 1H-MRS spectra were obtained with ECG and
navigator gated with water suppressed (32 averages) and
unsuppressed (4 averages) PRESS, TR/TE = 1-RR/30 ms.
Fat content was quantified with Amares/MRUI and related
to water in unsuppressed spectra and expressed as fat/
water percent ratios.
Results
The characteristics of study participants are presented in
Table 1. Using a 1% cut-off for cardiac steatosis, the over-
all prevalence of cardiac steatosis was 32% (14/44). The
prevalence of cardiac steatosis in cocaine users was signif-
icantly higher than that in those who did not use cocaine
(65.7% in cocaine users, and 16.7% in cocaine non-users,
p < 0.004). Exact logistic regression analysis indicated that
after controlling for age, gender, glucose, triglycerides, and
systolic blood pressure, cocaine use was associated with a
14-fold risk of cardiac steatosis (adjusted OR 13.8, 95%
CI:1.1,169).
Conclusion
This pilot study demonstrated that cocaine use is signifi-
cantly associated with cardiac steatosis. Human studies
indicate that cardiac steatosis is associated with impaired
left ventricular filling dynamics and diastolic dysfunction
[2]. However, we cannot discriminate whether there is a
causal relationship between increased myocardial TG con-
tent and reduced left ventricular function in our current
study due to limited number of participants. Further stud-
ies are under way to make these distinctions.
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Table 1: Characteristics of Study Participants of the Pilot Study
Cocaine use N = 32 never use N = 12
Female gender 45.7 ± 6.7 42.8 ± 9.5
Smoking/Diabetes 39.4%/9.1% 46.2%/0.0%
Systolic/Diastolic bp (mmhg) 130 ± 18/81 ± 12 123 ± 37/79 ± 18
Cholesterol (mg/dL) 174 ± 36 168 ± 35
Fasting glucose/Triglycerides (mg/dL) 97 ± 36/131 ± 103 84 ± 10/62 ± 25
Body Mass Index 27.5 ± 5.5 28.5 ± 6.7
LV end systolic/diastolic volume (mL) 61 ± 17/152 ± 34 69 ± 18/166 ± 27
Ejection Fraction (%) 60 ± 5 58 ± 8
LV mass (gm) 114 ± 28 118 ± 21Page 2 of 2
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